Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Brigham and Women's Hospital
With
Shonan Kamakura General Hospital
Cardiovascular Center Sakakibara Hospital
Shiritsu Hakodate Hospital
Sakurakai Takahashi Hospital
Sapporo Higashi Tokushukai Hospital
Kyoto Katsura Hospital
Kokura Memorial Hospital
Shonan Atsugi Hospital
New Tokyo Hospital
Aomori Prefectural Central Hospital
Kanto Rosai Hospital
Shin Koga Hospital
Higashi Takarazuka Satoh Hospital
Jichi Medical University
Kumamoto Rosai Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age at least 18 years old
Presentation with an ACS (unstable angina pectoris, non-ST elevation MI, or ST-elevation MI)
Coronary artery disease with at least one coronary segment requiring percutaneous stent deployment using usual clinical indications
At least 1 vessel suitable for IVUS not planned for PCI.
Have the ability to understand the requirements of the study, provide written informed consent
You may not be if
Heart failure, defined as NYHA Class III or IV
Unstable clinical status (ongoing anginal pain or hemodynamic or electrical instability)
Left main disease or three vessel disease
In the opinion of the investigator, significant coronary calcification precluding protocol evaluations
Investigator determination of renal failure of sufficient severity such that additional contrast material is contraindicated
Clinically significant valvular heart disease
Investigator opinion of life expectancy \< 12 months
Subject is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints. (Note: Studies requiring extended follow-up for products that were investigational, but have since become commercially available, are not considered investigational studies)
Women who are pregnant, seeking to become pregnant or suspect they are pregnant.
Clareo Health | Prediction of Progression of Coronary Artery Disease (CAD) Using Vascular Profiling of Shear Stress and Wall Morphology
